Aurobindo Pharma Ltd - Financial Analysis Review
Summary
Aurobindo Pharma Limited (Aurobindo Pharma) is a pharmaceutical company. The company engages in manufacturing active pharmaceutical ingredients (APIs), intermediates and generic formulations. The product portfolio encompasses of 250 finished dosage formulations and 200 API with diversified products. Aurobindo Pharma offers products for the treatment of cardio vascular, central nervous system, anti-retroviral, gastro-intestinal, anti-infective, pain management and osteoporosis. The company has received approvals for both API and formulation facilities from regulatory agencies such as UKMHRA, WHO, Health Canada, MCC South Africa, USFDA and ANVISA-Brazil.
Global Markets Direct’s "Aurobindo Pharma Ltd - Financial Analysis Review” is an in-depth business and financial analysis of Aurobindo Pharma Ltd. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
And More inside the report…
Recent Developments
Dec 17, 2009: Aurobindo Pharma Receives FDA Approval For Cetirizine Hydrochloride Syrup
Nov 27, 2009: Pfizer Hopes On Indian Pharma Company
Nov 23, 2009: Aurobindo Pharma Inaugurates Manufacturing Facility In Hyderabad, India
Scope
- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.
Report Highlights
The following companies are the major competitors of Aurobindo Pharma Ltd:
Divis Laboratories Limited
GlaxoSmithKline plc
IPCA Laboratories Limited
Sun Pharmaceutical Industries Limited
Matrix Laboratories Limited
Hikal Limited
[Studien Infos ausblenden]
